1
|
Monteiro T, Wysocka M, Tellez E, Monteiro O, Spencer L, Veiga E, Monteiro S, de Pina C, Gonçalves D, de Pina S, Ludgero-Correia A, Moreno J, Conceição T, Aires-de-Sousa M, de Lencastre H, Gray LJ, Pareek M, Jenkins DR, Beleza S, Oggioni MR, Araujo II. A five-year retrospective study shows increasing rates of antimicrobial drug resistance in Cabo Verde for both Staphylococcus aureus and Escherichia coli. J Glob Antimicrob Resist 2020; 22:483-487. [PMID: 32348903 DOI: 10.1016/j.jgar.2020.04.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 03/31/2020] [Accepted: 04/03/2020] [Indexed: 11/18/2022] Open
Abstract
OBJECTIVES Data on baseline drug resistance important in informing future antimicrobial stewardship programs. So far, no data on the antimicrobial drug resistance of clinical isolates available for the African archipelago of Cabo Verde. METHODS We performed a retrospective analysis over years (2013-17) of the drug susceptibility profiles of clinical isolates in the two main hospitals of Cabo Verde. For Escherichia coli and Staphylococcus aureus, representing 47% and 26% of all clinical isolates, the antimicrobial drug resistance profile was reported for six representative drugs. RESULTS For E. coli we detected an increase in resistance to ampicillin, amoxicillin/clavulanic acid, ceftriaxone, ciprofloxacin and trimethoprim-and for S. aureus to methicillin, erythromycin and trimethoprim-sulfamethoxazole. This increase in both the most commonly isolated bacterial pathogens is alarm as it might compromise empirical treatment in a setting with limited access to laboratory testing. CONCLUSIONS When compared to the published low resistance rates in carriage isolates, the more alarming situation in clinical isolates for S. aureus might encourage antimicrobial stewardship programs to reduce in hospital settings, possibly as part of the Cabo Verdean national plan against antimicrobial drug resistance.
Collapse
Affiliation(s)
- Tamar Monteiro
- Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia, Santiago, Cabo Verde
| | - Magdalena Wysocka
- Department of Genetics and Genome Biology, University of Leicester, Leicester, UK; Department of Molecular Biotechnology and Microbiology, Gdansk University of Technology, Gdansk, Poland
| | - Elena Tellez
- Hospital Agostinho Neto, Ministério da Saúde e Segurança Social, Praia, Santiago, Cabo Verde
| | - Ofelia Monteiro
- Hospital Agostinho Neto, Ministério da Saúde e Segurança Social, Praia, Santiago, Cabo Verde
| | - Luzia Spencer
- Hospital Agostinho Neto, Ministério da Saúde e Segurança Social, Praia, Santiago, Cabo Verde
| | - Elisa Veiga
- Hospital Agostinho Neto, Ministério da Saúde e Segurança Social, Praia, Santiago, Cabo Verde
| | - Sandra Monteiro
- Hospital Baptista de Sousa, Ministério da Saúde e Segurança Social, Mindelo, São Vicente, Cabo Verde
| | - Carine de Pina
- Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia, Santiago, Cabo Verde
| | - Deisy Gonçalves
- Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia, Santiago, Cabo Verde
| | - Sandrine de Pina
- Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia, Santiago, Cabo Verde
| | | | - Joao Moreno
- Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia, Santiago, Cabo Verde
| | - Teresa Conceição
- Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal
| | - Marta Aires-de-Sousa
- Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal
| | - Herminia de Lencastre
- Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal; Laboratory of Microbiology & Infectious Diseases, The Rockefeller University, New York, USA
| | - Laura J Gray
- Department of Health Sciences, University of Leicester, Leicester, UK
| | - Manish Pareek
- Department of Respiratory Sciences, University of Leicester, Leicester, UK
| | - David R Jenkins
- Department of Clinical Microbiology, University Hospitals of Leicester, NHS Trust, Leicester, UK
| | - Sandra Beleza
- Department of Genetics and Genome Biology, University of Leicester, Leicester, UK
| | - Marco R Oggioni
- Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
| | - Isabel Inês Araujo
- Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia, Santiago, Cabo Verde
| |
Collapse
|